New York State Common Retirement Fund Unity Biotechnology, Inc. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$2.91 - $4.5 $826 - $1,278	-284 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$4.15 - $6.3 $105,061 - $159,490	-25,316 Reduced 98.89%	284 $1,000
Q4 2019 Feb 05, 2020	BUY	$5.99 - $8.38 $4,792 - $6,704	800 Added 3.23%	25,600 $185,000
Q1 2019 May 08, 2019	BUY	$7.65 - $16.66 $137,700 - $299,880	18,000 Added 264.71%	24,800 $201,000
Q2 2018 Aug 10, 2018	BUY	$12.76 - $16.94 $86,768 - $115,192	6,800 New	6,800 $102,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $18.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.